Foundation for Innovative New Diagnostics
Also known as Find
Foundation for Innovative New Diagnostics reported $49.3 million in revenue and $56.8 million in expenses for calendar year 2024. Of every $100 it spent, $81.16 went to program services, $17.62 to management and general costs and $1.22 to fundraising. Its largest source of revenue was contributions and grants: 94.5% of the total. Government grants made up 40.9%. The highest compensation it reported for one person was $414,021 (DEPUTY DIRECTOR, FINANCE (THRU 11/24)). 123 people received more than $100,000 in reportable compensation. Revenue fell 50% between 2020 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $57MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $49MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 81.2% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 17.6% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 1.2% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.01 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 94.5% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 40.9% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.0% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $414,021 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 0.73% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 123 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 1.8 | 13.3 |
| Independent voting board members Part VI 1a–1b | 9 of 9 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseNo description in Part III; see the filing.
No description in Part III; see the filing.
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| DEPUTY DIRECTOR, FINANCE (THRU 11/24) Key employee, 40.0 hrs/week | $342,536 | $0 | $71,485 | $414,021 |
| CHIEF TECHNOLOGY OFFICER (thru 10/24) Officer, 40.0 hrs/week | $285,980 | $0 | $70,585 | $356,565 |
| CHIEF MEDICAL OFFICER (thru 9/24) Officer, 40.0 hrs/week | $284,240 | $0 | $59,142 | $343,382 |
| DIRECTOR, HUMAN RESOURCES Highest compensated employee, 40.0 hrs/week | $260,701 | $0 | $52,305 | $313,006 |
| DIRECTOR, TUBERCULOSIS PROGRAMME Highest compensated employee, 40.0 hrs/week | $244,800 | $0 | $53,973 | $298,773 |
| SENIOR DIRECTOR, IMPACT Highest compensated employee, 40.0 hrs/week | $265,429 | $0 | $31,260 | $296,689 |
| Director Strategic Information Highest compensated employee, 40.0 hrs/week | $235,091 | $0 | $54,490 | $289,581 |
| SENIOR DIRECTOR, PROGRAMME OPERATIONS (thru 7/24) Officer, 40.0 hrs/week | $230,858 | $0 | $38,285 | $269,143 |
123 people received more than $100,000 in reportable compensation from Foundation for Innovative New Diagnostics (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.9M (Part IX, line 5).
5 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b9 · 9 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aNo
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 5227
- Volunteers Part I, line 63
Largest outside contractors
2024 · Form 990, Part VII, Section B · businesses only| WORLD HEALTH ORGANIZATION Public-health technical support | $7,000,000 |
| INSTITUTE PASTEUR OF DAKAR Research and laboratory diagnostics | $4,537,400 |
| AIRPLUS INTERNATIONAL Flight arrangment services | $1,289,682 |
| GLOBAL FUND GLOBAL HEALTH CAMPUS Office space provider | $742,311 |
| INTERHYVE SARL It support services | $601,887 |
Individuals listed as contractors are left out. 105 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from Foundation for Innovative New Diagnostics's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Foundation for Innovative New Diagnostics, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Foundation for Innovative New Diagnostics spent in 2024, $81.16 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Critical Path InstituteTucson, AZ · revenue $47M · programs 77.9% · FY2025
- Huntsman Cancer FoundationSalt Lake City, UT · revenue $52M · programs 85.3% · 2024
- Gary and Mary West Health InstituteLA Jolla, CA · revenue $45M · programs 83.0% · 2024
- Dean McGee Eye InstituteOklahoma City, OK · revenue $54M · programs 68.7% · FY2025
- Alliance for Clinical Trials in Oncology FoundationChicago, IL · revenue $45M · programs 79.0% · 2024
Questions people ask
How much of Foundation for Innovative New Diagnostics's spending goes to programs?
In calendar year 2024, Foundation for Innovative New Diagnostics reported that 81.2% of its $56.8 million in expenses went to program services, 17.6% to management and general and 1.2% to fundraising (Form 990, Part IX).
How much does Foundation for Innovative New Diagnostics pay its top executive?
The largest total compensation Foundation for Innovative New Diagnostics reported for one person in calendar year 2024 was $414,021, for the role of DEPUTY DIRECTOR, FINANCE (THRU 11/24) (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Foundation for Innovative New Diagnostics get its money?
Of $49.3 million in revenue in calendar year 2024, 94.5% came from contributions and grants (including 40.9% from government grants) and 0.0% from program service revenue (Form 990, Part VIII).
Is Foundation for Innovative New Diagnostics a registered charity?
The IRS lists EIN 98-0407553 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202523219349318337 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202433209349311393 · read the filing
- 2022: Form 990 for calendar year 2022, object 202343199349316034 · read the filing
- 2021: Form 990 for calendar year 2021, object 202203199349309895 · read the filing
- 2020: Form 990 for calendar year 2020, object 202113199349315546 · read the filing
All filings for EIN 98-0407553: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.